The reduction in the price target by Truist Securities suggests a less optimistic outlook on Quest Diagnostics' stock value in the short term. This adjustment could lead to a negative perception among investors, potentially causing a decrease in the stock price. The Hold rating indicates that the analyst does not see significant upside or downside in the near term, but the lowering of the price target is a bearish signal.